[BiO BB] Adopting Integrated R&D Informatics Systems

Jim Prudhomme jprudhomme at healthtech.com
Wed Dec 3 16:41:24 EST 2008


Final Conference Details Posted for:

CHI’s Adopting Integrated R&D Informatics Systems

February 25-27, 2009 
Moscone North Convention Center, San Francisco, CA
http://www.tri-conference.com/09_ird.asp


AGENDA-AT-A-GLANCE



PRE-CONFERENCE SHORT COURSE*

Tuesday, February 24 - 2:00 - 5:00 pm

 

(SC6) Best Practices in Translational Medicine, Drug Discovery 

and Informatics

 

This course provides you with an inside look at several of the outstanding
Best Practices presented as a part of the 2008 Bio-IT World Best Practices
competition. Speakers will present their best practices, give updates to the
program and discuss pushing innovation, increasing ROI, and implementing
strategies that are the best in the industry. The forum will be invaluable
for building the innovative partnerships and strategies that will keep
pushing the industry forward.   * Separate registration is required.

 

MAIN CONFERENCE

February 25-27, 2009

 

INTEGRATED R&D - DRIVING PRODUCTIVITY, INNOVATION & MANAGING RESOURCES &
COSTS

 

PLENARY KEYNOTE: 

Using Molecular Medicine to do Therapeutic Development in the Network Age

Jay M. Tenenbaum, Ph.D., Chairman and Chief Scientist, CollabRx, Inc.

 

Scientific Workflows as Productivity Tools for Drug Discovery

Juergen Hammer, Ph.D., M.Sc., M.B.A., Global Research Informatics Director,
Group Research Information- Global Head in silico Sciences - Center Head -
Liaison to Pharma Research, Hoffmann-La Roche Inc. 

 

The Role of Informatics and Genomics to Drive Innovation in Pharma 

Jakob DeVlieg, Ph.D., Global Head Molecular Design & Informatics, Molecular
Design & Informatics, Schering-Plough

 

Evolution of an Innovation Model to Support Pharma R&D

Martin D. Leach, Ph.D., Executive Director, MRL IT Basic Research &
Biomarkers, Merck & Co. Inc.

 

RISé - Research Informatics System at RISé 

Ajay Shah, Ph.D., M.B.A., P.M.P., Director, Research Informatics, Elan
Pharmaceuticals Inc.     Sponsored by: Symyx

 

Resource Management Strategies Impacting Systems Integration in R&D

David M. Sedlock, Ph.D.. Senior Director, R&D Systems, Millennium
Pharmaceuticals The TAKEDA Oncology Company

 

Democratized Serendipity: Leveraging Consumer-Oriented Technologies into
Better R&D and Better Health Care Decisions

Joseph A. Cerro, President, The Schooner Group, LLC

 

Executive Panel:

Integrated R&D, How Far Have We Come?

Moderator: Susan Ward, Ph.D.,Executive Advisor, Biotechnology & Pharma 

Panelists: All of the above speakers

 

TRANSLATIONAL RESEARCH INFORMATICS

 

Enterprise Information Integration to Inform Biomarker Discovery and
Development: Clinical Patient, Biosample and Omics Data

Gary Mallow, Ph.D., Director, Biomarker Programs, Information Services for
Basic Research, Merck & Co., Inc.

 

A Nationwide Network to Enable Translational Research

Ken Buetow, Ph.D., NCI Associate Director, Bioinformatics and Information
Technology and Director, Center for Biomedical Informatics and Information 

 

Technology, National Cancer Institute

Translating Between Pre-clinical Data and Clinical Outcomes: Successes and
Challenges

Anastasia M. Khoury Christianson, Ph.D., Senior Director and Global
Discipline Leader, Biomedical Informatics, AstraZeneca R&D Wilmington 

 

How to get the Most Out of Published Findings: Improving Information Flow
and Knowledge Enrichment Throughout Discovery 

Nikolai Daraselia, Ph.D., Senior Director of Research, Ariadne

Sponsored by Ariadne

 

Scientific Informatics: The Integration of Information and Process to
Achieve Knowledge Re-Use

Frank K. Brown, Ph.D., Vice President & Chief Science Officer, Accelrys

Sponsored by Accelrys

 

Integrated Informatics - Are We There Yet?

Sandor Szalma, Ph.D., Director, R&D Informatics, Centocor R&D Inc.

 

Panel: Bridging the Divide

Moderator: John Russell, Executive Editor, Bio-IT World 

Panelists: All of the above speakers

 

Analysis of Genome-wide Genotyping Data for Copy Number Variation in Breast
Cancer

Aubree Hoover, Senior Product Manager, Rosetta Biosoftware

Sponsored by Rosetta Biosoftware

 

PLENARY KEYNOTE 

Engineering Cells to Death 

James A. Wells, Ph.D., Professor and Chair of Pharmaceutical Chemistry, and
Professor of Cellular & Molecular Pharmacology, University of California,
San Francisco

 

PLENARY KEYNOTE 

Brave New Age of Personalized Medicine

David Ewing Duncan, Chief Correspondent, NPR Talk's "Biotech Nation" and
Best Selling Author "Masterminds"

 

DATA, INFORMATION AND KNOWLEDGE MANAGEMENT 

Tales from the Edge: Advanced Approaches to Knowledge Integration & Search

David M. Hodgson, Site Head, Global Research Informatics & Global Head,
Group Knowledge Exchange, Roche

 

A Strategy for Internal-External Data and Information Integration

Jason M. Johnson, Ph.D., Senior Director, Molecular Informatics, Merck &
Co., Inc.

 

Accelerating Research Through Information Exploitation

Chris Waller, Ph.D., Senior Director, Chemistry Informations, Research and
Development Informatics, Worldwide Technology, Pfizer, Inc.

Integrating Public and Private Data

 

Reece Hart, Ph.D., Scientific Manager, Research Computing & Informatics,
Genentech Inc.

 

INTEGRATING GENOMIC DATA

The Genomic Data Pipeline: Collecting, Cleaning, Analyzing, Integrating,
Sharing

Jeanette Papp, Ph.D., Associate Professor, Human Genetics, University of
California, Los Angeles

 

Surviving the Data Deluge: Informatics for Next Generation Sequencing

Toby Bloom, Ph.D, Director of Informatics, Genome Sequencing Platform, The
Broad Institute

 

Integrating Public Genomics Data into Pharmaceutical R&D

Hans-Martin Will, Ph.D., Senior Director, Genomics R&D, Rosetta Biosoftware

 

Search Strategies for Correlating Combined Public and Internal Large-Scale
Studies

Ilya Kupershmidt, Cofounder and Vice President Products, NextBio

Sponsored by NextBio

 

Panel: Meeting of the Minds 

Those who Generate the Data with Those who Store, Analyze and Integrate Data

 

DATA INTEGRATION AND MANAGEMENT FOR EARLY AND LATE CHEMISTRY

 

Lilly's Transition from Paper to Electronic Lab Notebooks

Keith DeVries, Ph.D., Director, Chemical Product, R&D, Eli Lilly and
Company, Lilly Research Labs 

 

Integration of Chemical Genomics and Structural Biology Informatics: Novel
Insights into the Kinase Gene Family?

Stephan Schürer, Ph.D., Department of Pharmacology, Miller School of
Medicine & Center for Computational Science, University of Miami

 

Techniques for Effective Integrated Access to Large Compound-oriented Drug
Discovery Databases

Michael, Lajiness, Ph.D., Research Scientist, Structural and Computational
Sciences, Eli Lilly & Company 

*separate registration is required to attend pre-conference short course.

http://www.tri-conference.com/09_ird.asp

For more information, contact:
Cambridge Healthtech Institute
Tel: 781-972-5400
E-mail: jprudhomme at healthtech.com

 

 




More information about the BBB mailing list